Land parcels of pharma PSUs find no takers, but momentum likely in few mths

In December 2019 the decision was revised to allow sale of land to private entities as well through a competitive bidding process

There are no easy takers for land parcels of pharmaceutical (pharma) public sector undertakings (PSUs) after the process was set into motion in 2016. However, independent valuation of land parcels is now being done, and PSU sources indicate that the process of sale may gather momentum in the months to come.

Initially, the bidding was restricted to government agencies, and several tenders issued by PSUs for sale of surplus land did not find any takers.

“Since land could not be sold, the liabilities of PSUs could not be met and no progress made in respect of their closure or strategic